Diclofenac Sodium

Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and reduce inflammation associated with musculoskeletal conditions such as arthritis, tendonitis, and acute injury.

It works by inhibiting cyclooxygenase (COX) enzymes, thereby decreasing the production of prostaglandins—chemical mediators that drive pain, swelling, and inflammation. 

Diclofenac is available in multiple formulations, including oral tablets, topical gels, patches, and injectable formulations, allowing clinicians to tailor treatment to the severity and location of pain.

Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.

What Is Voltaren?

Voltaren is the brand-name formulation of diclofenac. It is widely recognized for its efficacy in managing inflammatory pain and is available in both prescription and over-the-counter formulations, depending on the specific formulation and strength.

Voltaren Gel is widely used topically, delivering diclofenac directly to affected joints or muscles while minimizing systemic exposure. This makes it a common option for localized pain relief in conditions like osteoarthritis of the hands or knees.

Voltaren is used for both chronic and acute pain management, often associated with inflammation. Its efficacy in addressing pain makes it a first-line choice for several conditions.

Primary Indications

Primary applications of Voltaren include alleviating symptoms of osteoarthritis and rheumatoid arthritis. Patients often use it to relieve joint pain associated with these conditions, particularly when discomfort is localized in joints such as the knees, hands, and feet.

The topical form, Voltaren Gel, is specifically formulated for use on these joints, providing targeted action with minimal systemic exposure.

Off-Label Uses

In addition to its primary indications, healthcare providers occasionally prescribe Voltaren for off-label use. Conditions such as chronic lower back pain and some types of headaches may benefit from its anti-inflammatory properties, although the FDA doesn’t officially approve these uses.

The decision to use Voltaren for these purposes depends on a healthcare provider’s judgment, given the lack of large-scale studies supporting these applications. Some rheumatologists may use it to manage inflammation associated with certain non-FDA-approved conditions.

Voltaren’s mechanism of action hinges on its ability to inhibit enzymes essential to inflammatory processes. Its unique formulation delivers selective, localized pain relief.

Mechanism of Action

Voltaren operates by targeting cyclooxygenase (COX) enzymes—specifically COX-1 and COX-2. These enzymes catalyze the formation of prostaglandins, which are pro-inflammatory chemicals produced at sites of tissue damage or infection.

By blocking these enzymes, Voltaren reduces prostaglandin synthesis, decreasing pain, swelling, and inflammation. This makes Voltaren particularly effective for conditions where inflammation is a primary symptom.

Pharmacokinetics

The pharmacokinetics of Voltaren differ notably between its oral and topical formulations. When applied as a gel, Voltaren is absorbed through the skin layers, delivering localized relief directly to the affected area.

This method of administration minimizes systemic absorption, thus reducing the risk of adverse systemic effects commonly associated with oral NSAIDs, such as gastrointestinal discomfort and kidney stress. 

The gel’s absorption and action are tailored for localized tissues, making it a preferable option for those seeking targeted relief with a minimal systemic footprint.

Proper dosing and administration of Voltaren are crucial for maximizing its effectiveness while minimizing potential side effects. Different formulations and conditions necessitate specific guidelines.

Dosage Recommendations

The Voltaren Gel dosage is generally determined by the size of the area being treated. The recommended application is a thin layer over the affected area up to four times daily. The amount applied should align with instructions provided by the prescribing healthcare provider or outlined on the medication packaging.

A dosing card is often included with the gel, enabling precise dosing and preventing over-application. For oral formulations, dosages typically vary with the severity of the condition and the patient’s response and are generally prescribed by healthcare providers as needed.

Administration Guidelines

When applying Voltaren Gel, ensure that the skin surface is clean and dry. Avoid application to broken or infected skin. Rub the gel gently over the affected area and wash your hands thoroughly before and after usage to avoid unintentional contact with mucus membranes.

It is crucial not to cover the treated area with a bandage or wrap that doesn’t allow airflow unless directed by a healthcare provider. 

For areas such as the hips, where precise application may be challenging, consult detailed guidelines or a healthcare professional. Ensure that patients do not apply the gel to large areas of the body unless advised, and maintain focus on the specified application sites, such as the knees and hands, to optimize results.

21-Day Reset (2025 Guidance): Voltaren Gel is intended for short-term pain flares, not continuous use. Newer OTC guidance limits use to 21 consecutive days, followed by a minimum 7-day break, to reduce chronic skin irritation and cumulative kidney stress. If pain persists beyond 3 weeks, medical evaluation, physical therapy, or a different treatment approach may be warranted rather than ongoing NSAID exposure.

While Voltaren is generally well-tolerated, users should be vigilant for potential side effects. Understanding these risks can contribute to a safer treatment experience.

Common Side Effects

Typical side effects of Voltaren Gel include:

• Redness, itching, or a mild rash may occur with direct application of the gel to the skin and typically subside as the skin adjusts to the treatment.
• Dry skin or mild peeling at the site of application may also occur. 
• Gastrointestinal discomfort may occur with topical Voltaren application, although this is less common than with oral NSAIDs.

Serious Side Effects

Although serious side effects are rare with Voltaren Gel, they can occur. Potential serious adverse reactions include:

• Gastrointestinal bleeding, especially in individuals with a history of peptic ulcers or gastrointestinal diseases.
• Kidney function may also be affected, but this is more common with absorption from oral formulations.
• Serious skin reactions, although rare, can manifest as severe redness, peeling, or blistering and require immediate medical attention.
• Heart & Stroke Risk (2025 Safety Alert): The FDA’s Black Box Warning highlights that diclofenac carries a slightly higher risk of heart attack and stroke than naproxen, with risk possible within the first week of use. Patients with prior CABG or a recent heart attack should not use oral Voltaren, and 2025 guidance favors topical Voltaren Gel, which delivers ~95% less systemic drug exposure.

Patients are advised to monitor for signs of these serious side effects, especially if they have preexisting conditions that could predispose them to complications from NSAID use.

Voltaren’s interactions with other medications can modify its effectiveness or increase the risk of adverse effects. Understanding these interactions ensures safe use alongside other drugs.

Primary Drug Interactions

• Hidden NSAID Overdose (“Accidental Stacking”): Using Voltaren alongside other NSAIDs (like ibuprofen or naproxen) greatly increases the risk of stomach ulcers and acute kidney injury. With Voltaren Gel now OTC, many patients unknowingly “double up” by applying the gel while taking oral NSAIDs. Newer guidance states that if you are using Voltaren Gel, the only safe oral option for additional pain relief is acetaminophen (Tylenol), which is not an NSAID.
• Antihypertensive Agents: Caution is advised when used with antihypertensive agents, as NSAIDs can potentially diminish their efficacy, leading to higher blood pressure levels. 
• Anticoagulants: Combining Voltaren with anticoagulants such as warfarin or aspirin may increase the risk of bleeding due to additive anticoagulant effects.
• SSRIs: Some antidepressants, particularly SSRIs, may increase bleeding risks when taken concurrently with Voltaren.

A comprehensive review of a patient’s full medication list is critical to prevent adverse reactions.

Other Considerations

When using Voltaren Gel, the risk of interactions is reduced, yet caution should be exercised with other drugs that affect cardiovascular or renal function. Patients should inform healthcare providers of any over-the-counter supplements, as interactions may occur with herbs or dietary supplements that impact blood clotting or inflammation.

Skin Protection Alert: Diclofenac can cause photosensitivity. In 2025, patients are advised that treated skin (e.g., knees or hands) is much more likely to burn when exposed to sunlight. If you apply Voltaren Gel and spend time outdoors, you must cover the area with clothing or wait until the gel is completely dry and apply a broad-spectrum sunscreen over it.